Literature DB >> 27372566

CD23 surface density on B cells is associated with IgE levels and determines IgE-facilitated allergen uptake, as well as activation of allergen-specific T cells.

Regina Selb1, Julia Eckl-Dorna1, Alina Neunkirchner2, Klaus Schmetterer3, Katharina Marth4, Jutta Gamper5, Beatrice Jahn-Schmid6, Winfried F Pickl2, Rudolf Valenta4, Verena Niederberger7.   

Abstract

BACKGROUND: Increasing evidence suggests that the low-affinity receptor for IgE, CD23, plays an important role in controlling the activity of allergen-specific T cells through IgE-facilitated allergen presentation.
OBJECTIVE: We sought to determine the number of CD23 molecules on immune cells in allergic patients and to investigate whether the number of CD23 molecules on antigen-presenting cells is associated with IgE levels and influences allergen uptake and allergen-specific T-cell activation.
METHODS: Numbers of CD23 molecules on immune cells of allergic patients were quantified by using flow cytometry with QuantiBRITE beads and compared with total and allergen-specific IgE levels, as well as with allergen-induced immediate skin reactivity. Allergen uptake and allergen-specific T-cell activation in relation to CD23 surface density were determined by using flow cytometry in combination with confocal microscopy and T cells transfected with the T-cell receptor specific for the birch pollen allergen Bet v 1, respectively. Defined IgE-allergen immune complexes were formed with human monoclonal allergen-specific IgE and Bet v 1.
RESULTS: In allergic patients the vast majority of CD23 molecules were expressed on naive IgD+ B cells. The density of CD23 molecules on B cells but not the number of CD23+ cells correlated with total IgE levels (RS = 0.53, P = .03) and allergen-induced skin reactions (RS = 0.63, P = .008). Uptake of allergen-IgE complexes into B cells and activation of allergen-specific T cells depended on IgE binding to CD23 and were associated with CD23 surface density. Addition of monoclonal IgE to cultured PBMCs significantly (P = .04) increased CD23 expression on B cells.
CONCLUSION: CD23 surface density on B cells of allergic patients is correlated with allergen-specific IgE levels and determines allergen uptake and subsequent activation of T cells.
Copyright © 2016 American Academy of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  B cell; CD23; IgE; allergen; allergy; low-affinity IgE receptor

Mesh:

Substances:

Year:  2016        PMID: 27372566      PMCID: PMC5321593          DOI: 10.1016/j.jaci.2016.03.042

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  45 in total

1.  Endocytosis, storage, and release of IgE by human platelets: differences in patients with type I allergy and nonatopic subjects.

Authors:  M Klouche; M H Klinger; W Kühnel; D Wilhelm
Journal:  J Allergy Clin Immunol       Date:  1997-08       Impact factor: 10.793

Review 2.  IgE-mediated allergen presentation and blocking antibodies: regulation of T-cell activation in allergy.

Authors:  R J J van Neerven; E F Knol; A Ejrnaes; P A Würtzen
Journal:  Int Arch Allergy Immunol       Date:  2006-07-21       Impact factor: 2.749

3.  Blocking antibodies induced by specific allergy vaccination prevent the activation of CD4+ T cells by inhibiting serum-IgE-facilitated allergen presentation.

Authors:  R J van Neerven; T Wikborg; G Lund; B Jacobsen; A Brinch-Nielsen; J Arnved; H Ipsen
Journal:  J Immunol       Date:  1999-09-01       Impact factor: 5.422

4.  Immuno-evasive tactics by schistosomes identify an effective allergy preventative.

Authors:  Qyana Griffith; YanMei Liang; Patrick Whitworth; Carlos Rodriguez-Russo; Ahmad Gul; Afzal A Siddiqui; John Connor; Pauline Mwinzi; Lisa Ganley-Leal
Journal:  Exp Parasitol       Date:  2015-03-24       Impact factor: 2.011

5.  Humanized anti-IgE mAb Hu-901 prevents the activation of allergen-specific T cells.

Authors:  R J van Neerven; C P van Roomen; W R Thomas; M de Boer; E F Knol; F M Davis
Journal:  Int Arch Allergy Immunol       Date:  2001 Jan-Mar       Impact factor: 2.749

6.  Anti-CD23 monoclonal antibody, lumiliximab, inhibited allergen-induced responses in antigen-presenting cells and T cells from atopic subjects.

Authors:  Jill A Poole; Jianfeng Meng; Mitchell Reff; Mary C Spellman; Lanny J Rosenwasser
Journal:  J Allergy Clin Immunol       Date:  2005-10       Impact factor: 10.793

7.  Cytokine regulation of low-affinity IgE receptor (CD23) on monocytes from asthmatic subjects.

Authors:  A Vecchiarelli; A Siracusa; C Monari; D Pietrella; C Retini; C Severini
Journal:  Clin Exp Immunol       Date:  1994-08       Impact factor: 4.330

8.  Serum-IgE-facilitated allergen presentation in atopic disease.

Authors:  F L van der Heijden; R J Joost van Neerven; M van Katwijk; J D Bos; M L Kapsenberg
Journal:  J Immunol       Date:  1993-04-15       Impact factor: 5.422

9.  Distinct modulation by interferon-gamma (IFN-gamma) of CD23 expression on B and T lymphocytes of atopic subjects.

Authors:  M Corominas; M Mestre; J Bas; E Buendia
Journal:  Clin Exp Immunol       Date:  1998-05       Impact factor: 4.330

10.  Omalizumab reverses the phenotypic and functional effects of IgE-enhanced Fc epsilonRI on human skin mast cells.

Authors:  Gregorio Gomez; Sherryline Jogie-Brahim; Mika Shima; Lawrence B Schwartz
Journal:  J Immunol       Date:  2007-07-15       Impact factor: 5.422

View more
  24 in total

1.  Lack of Ecto-5'-Nucleotidase Protects Sensitized Mice against Allergen Challenge.

Authors:  Elisabetta Caiazzo; Ida Cerqua; Roberta Turiello; Maria Antonietta Riemma; Giacomo De Palma; Armando Ialenti; Fiorentina Roviezzo; Silvana Morello; Carla Cicala
Journal:  Biomolecules       Date:  2022-05-13

2.  A positive feedback loop reinforces the allergic immune response in human peanut allergy.

Authors:  Xiaoying Zhou; Wong Yu; Elizabeth D Mellins; Kari C Nadeau; Shu-Chen Lyu; Claudia Macaubas; Bryan Bunning; Ziyuan He
Journal:  J Exp Med       Date:  2021-05-04       Impact factor: 14.307

Review 3.  Oral Mucosa as a Potential Site for Diagnosis and Treatment of Allergic and Autoimmune Diseases.

Authors:  Cristina Gomez-Casado; Javier Sanchez-Solares; Elena Izquierdo; Araceli Díaz-Perales; Domingo Barber; María M Escribese
Journal:  Foods       Date:  2021-04-28

4.  IgE binds asymmetrically to its B cell receptor CD23.

Authors:  Balvinder Dhaliwal; Marie O Y Pang; Anthony H Keeble; Louisa K James; Hannah J Gould; James M McDonnell; Brian J Sutton; Andrew J Beavil
Journal:  Sci Rep       Date:  2017-03-31       Impact factor: 4.379

5.  Bleomycin Aggravates Atopic Dermatitis via Lung Inflammation in 2,4-Dinitrochlorobenzene-Induced NC/Nga Mice.

Authors:  Yoon-Young Sung; Seung-Hyung Kim; Won-Kyung Yang; Yang-Chun Park; Ho Kyoung Kim
Journal:  Front Pharmacol       Date:  2018-06-01       Impact factor: 5.810

6.  Therapeutic vaccines for allergic disease.

Authors:  Danuta Gutowska-Owsiak; Graham S Ogg
Journal:  NPJ Vaccines       Date:  2017-05-08       Impact factor: 7.344

Review 7.  Gut Mucosal Antibody Responses and Implications for Food Allergy.

Authors:  Ramona A Hoh; Scott D Boyd
Journal:  Front Immunol       Date:  2018-09-27       Impact factor: 7.561

Review 8.  The Intersection of IgE Autoantibodies and Eosinophilia in the Pathogenesis of Bullous Pemphigoid.

Authors:  Kelly N Messingham; Tyler P Crowe; Janet A Fairley
Journal:  Front Immunol       Date:  2019-10-04       Impact factor: 7.561

Review 9.  Oral immunotherapy for food allergy.

Authors:  Deborah M Hussey Freeland; Monali Manohar; Sandra Andorf; Benjamin D Hobson; Wenming Zhang; Kari C Nadeau
Journal:  Semin Immunol       Date:  2017-08-31       Impact factor: 11.130

10.  Expressions of CD23, IL-17 and MMP-9 in Patients with Colorectal Cancer.

Authors:  Xueguang Guo; Gang Liu; Xiaoping Xie; Jing Li; Zehui Hou; Yanhong Gu; Lijiang Yu
Journal:  Iran J Public Health       Date:  2020-02       Impact factor: 1.429

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.